Clinical Trial Update: A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients [Phase 1]

View source ↗

Summary

A Phase I clinical trial update for ETH-155008 (Euthare-155008) in adult patients with non-Hodgkin lymphoma and recurrent acute myeloid leukemia. The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Euthare-155008 (ETH-155008)

Snippet

Sponsor: Shengke Pharmaceuticals (Jiangsu) Limited, China | Conditions: NHL, Adult, AML, Adult Recurrent | Phase 1 | Status: RECRUITING